The Role of Adiponectin in Atherosclerosis: do Lipids Tip the scales?
- 26 October 2005
- journal article
- Published by Taylor & Francis in Future Cardiology
- Vol. 1 (6) , 775-784
Abstract
Adiponectin may play a role in the pathophysiology of atherosclerosis, dyslipidemia and coronary artery disease. Thus, adiponectin administration diminishes atherosclerotic burden in experimental mouse models and high plasma adiponectin concentrations are associated with lower risk of myocardial infarction in men. Dyslipidemia is the strongest risk factor for coronary artery disease. Decreased adiponectin is associated with an atherogenic lipid profile of low high-density lipoprotein cholesterol and elevated triglycerides. However, little attention has been paid to this phenomenon to date. It is known that adiponectin is an important regulator of hepatic and muscle fatty acid oxidation. Two recent human studies suggest that adiponectin may influence activity and/or expression of hepatic lipase and lipoprotein lipase. These two plasma enzymes directly regulate concentrations of circulating lipoproteins. Future research may reveal the role of adiponectins in lipid metabolism, especially in affecting plasma high-density lipoprotein cholesterol levels. Adiponectin administration and regulation of the pathways controlling its production may prove beneficial as a therapeutic strategy in atherogenic dyslipidemia and atherosclerosis.Keywords
This publication has 34 references indexed in Scilit:
- Vascular and Metabolic Effects of Combined Therapy With Ramipril and Simvastatin in Patients With Type 2 DiabetesHypertension, 2005
- Adiponectin and Coronary Heart Disease: The Strong Heart StudyArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Low Plasma Adiponectin Levels Predict Progression of Coronary Artery CalcificationCirculation, 2005
- Complex Distribution, Not Absolute Amount of Adiponectin, Correlates with Thiazolidinedione-mediated Improvement in Insulin SensitivityJournal of Biological Chemistry, 2004
- Adiponectin: More Than Just Another Fat Cell Hormone?Diabetes Care, 2003
- Genetics of HDL regulation in humansCurrent Opinion in Lipidology, 2003
- Globular Adiponectin Protected ob/ob Mice from Diabetes and ApoE-deficient Mice from AtherosclerosisJournal of Biological Chemistry, 2003
- Adiponectin Reduces Atherosclerosis in Apolipoprotein E-Deficient MiceCirculation, 2002
- Disruption of Adiponectin Causes Insulin Resistance and Neointimal FormationJournal of Biological Chemistry, 2002
- Activation of Apolipoprotein AI Gene Expression by Protein Kinase A and Kinase C through Transcription Factor, Sp1Journal of Biological Chemistry, 2000